L-Type amino acid transporter 1 (LAT1) expression in malignant pleural mesothelioma

Anticancer Research

Volumn 31, Issue 12, 2011, Pages 4075-4082

  Kaira, Kyoichi ^a   Oriuchi, Noboru ^a   Takahashi, Toshiaki ^a   Nakagawa, Kazuo ^a   Ohde, Yasuhisa ^a   Okumura, Takehiro ^a   Murakami, Haruyasu ^a   Shukuya, Takehito ^a   Kenmotsu, Hirotsugu ^a   Naito, Tateaki ^a   Kanai, Yoshikatsu ^a   Endo, Masahiro ^b   Kondo, Haruhiko ^a   Nakajima, Takashi ^c   Yamamoto, Nobuyuki ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

CD98; Hypoxia; LAT1; Mesothelioma; mTOR; Prognosis

Indexed keywords

AMINO ACID TRANSPORTER; CD34 ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; HEXOKINASE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P53; TUMOR MARKER; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ADULT; AGED; ANOXIA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LARGE NEUTRAL AMINO ACID-TRANSPORTER 1; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MIDDLE AGED; PLEURAL NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84855181114     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Lee AY, Raz DJ, He B and Jablons DM: Update on the molecular biology of malignant mesothelioma. Cancer 109: 1454-1461, 2007. (Pubitemid 46595678)
2. Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Tanaka S, Ishizuka T, Kanai Y, Endou H, Nakajima T and Mori M: Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer. Br J Cancer 98: 742-748, 2008. (Pubitemid 351272621)
3. Kanai Y, Segawa H, Miyamoto K, uchino H, Takeda E and Endou H: Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 273: 23629-23632, 1998. (Pubitemid 28435687)
4. Oxender DL and Christensen HN: Evidence for two types of mediation of neutral amino acid transport in Ehrlich cells. Nature 197: 765-767, 1963.
5. Fuchs BC and Bode BP: Amino acid transporters ASCT2 and LAT1 in cancer: Partners in crime? Semi Cancer Biol 15: 254-266, 2006.
6. Yamauchi K, Sakurai H, Kimura T, Wiriyasermkul P, Nagamori S, Kanai Y and Kohno N: System L amino acid transporter inhibitor enhances antitumor activity of cisplatin in a head and neck squamous cell carcinoma cell line. Cancer Lett 276: 95-101, 276.
7. Imai H, Kaira K, Oriuchi N, Shimizu K, Tominaga H, Yanagitani N, Sunaga N, Ishizuka T, Nagamori S, Promchan K, Nakajima T, Yamamoto N, Mori M and Kanai Y: Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer. Anticancer Res 30: 4819-4828, 2010.
8. Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Tanaka S, Ishizuka T, Kanai Y, Endou H, Nakajima T and Mori M: L-Type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms. Cancer Sci 99: 2380-2386, 2008.
9. Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Nakajima T and Mori M: Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma. Lung Cancer 66: 120-126, 2009.
10. Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Kawshima O, Kamide Y, Ishizuka T, Kanai Y, Nakajima T and Mori M: CD98 expression is associated with poor prognosis in resected non-small cell lung cancer with lymph node metastasis. Ann Surg Oncol 16: 3473-3481, 2009.
11. 18F-FDG uptake in non-small cell lung cancer. Cancer Sci 100: 753-758, 2009.
12. Vleugel MM, Greijer AE, Shvarts, van der Groep, van Berkel M, Aarbodem Y, van Tinteren H, Harris AL, van Diest PJ and van der Wall E: Differential prognostic impact of hypoxia induced and diffuse HIF-1 alpha expression in invasive breast cancer. J Clin Pathol 58: 172-177, 2005. (Pubitemid 40193803)
13. Elson DA, Ryan HE, Snow JW, Johnson R and Arbeit JM: Coordinate up-regulation of hypoxia-inducible factor (HIF)-1a and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing 1. Cancer Res 60: 6189-195, 2000.
14. Ryan HE, Polni M, McNulty W, Elson D, Gassmann M, Arbeit JM and Johnson RS: Hypoxia-inducible factor-1α is a positive factor in solid tumor growth. Cancer Res 60: 4010-4015, 2000. (Pubitemid 30636574)
15. Younes M, Brown RW, Stephenson M, Gondo M and Cagle PT: Over expression of GLUTI and GLUT3 in stage I non-small cell lung carcinoma is associated with poor survival. Cancer 80: 1046-1051, 1997. (Pubitemid 27427603)
16. Soado RJ, Li JY, Tsukamoto H and Pardridge WH: Hypoxia induces de-stabilization of the LAT1 large neural amino acid transporter mRNA in brain capillary endothelial cells. J Neurochem 85: 1037-1042, 2003. (Pubitemid 36578635)
17. Ohno H, Nakatsu Y, Sakoda H, Kushiyama A, Ono H, Fujishiro H, Otani Y, Okubo H, Yoneda M, Fukushima T, Tsuchiya Y, Kamata H, Nishimura F, Kurihara H, Katagiri H, Oka Y and Asano T: 4F2hc stabilizes GLUT1 protein and increases glucose transport activity. Am J Physiol Cell Physiol 300: C1047-1054, 2010.
18. Rusch VW: The International Mesothelioma Interest Group: A proposed new international TNM staging system for malignant pleural mesothelioma. Chest 108: 1122-1128, 1995.
19. 18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors. J Clin Oncol 28: 3746-3753, 2010.
20. Nawashiro H, Otani N, Shinomiya N, Fukui S, Ooigawa H, Shima K, Matsuo H, Kanai Y and Endou H: L-Type amino acid transporter 1 as a potential molecular target in human astrocytic tumors. Int J Cancer 119: 484-492, 2006. (Pubitemid 43955699)
21. Chairoungdua A, Segawa H, Kim JY, Miyamoto K, Haga H, Fukui Y, Mizoguchi K, Ito H, Takeda E, Endou H and Kanai Y: Identification of an amino acid transporter associated with the cystinuria-related type II membrane glycoprotein. J Biol Chem 274: 28845-28848, 1999.
22. Ohkame H, Masuda H, Ishii Y and Kanai Y: Expression of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in liver tumor lesions of rat models. J Surg Oncol 78: 265-271; discussion 271-272, 2001.